Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    NIAID | Open Studies | Exclude Unknown | healthy
Show Display Options
Rank Status Study
21 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Health
Intervention:
22 Recruiting A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults
Condition: Healthy
Interventions: Biological: Ad26.Filo;   Biological: MVA-BN-Filo;   Biological: Ad26.ZEBOV;   Biological: Placebo
23 Recruiting Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Conditions: Healthy;   Rheumatoid Arthritis Prevention
Interventions: Drug: Hydroxychloroquine;   Drug: HCQ Placebo
24 Recruiting Tissue Biopsy and Imaging Studies in HIV-Infected Patients
Conditions: HIV;   Healthy Volunteers
Intervention:
25 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
26 Recruiting Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
Conditions: Microbiome;   Antibiotic-Induced VVC;   Vaginal Candidiasis
Intervention:
27 Recruiting Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
Condition: Influenza
Intervention: Biological: Trivalent inactivated influenza vaccine
28 Not yet recruiting MVA-BN®-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Conditions: Marburg Disease;   Ebola Disease
Interventions: Biological: MVA Multi-Filo Ebola Vaccine;   Biological: Ad26 Zaire Ebola Vaccine
29 Recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pneumococcal Infection;   Pneumonia;   Pathogen Resistance
Intervention: Drug: Colistimethate sodium
30 Recruiting Phase 1 Study of dmLT ID Vaccination in Healthy Adults
Condition: Gastroenteritis Escherichia Coli
Interventions: Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
31 Recruiting PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
Condition: Plasmodium Falciparum Infection
Interventions: Drug: Chloroquine;   Other: Placebo;   Biological: PfSPZ
32 Recruiting H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
Conditions: Avian Influenza;   Influenza
Interventions: Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine
33 Recruiting A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults
Condition: Schistosomiasis
Interventions: Biological: Sm-TSP-2/Alhydrogel;   Biological: Sm-TSP-2/Alhydrogel/GLA-AF;   Other: Placebo
34 Not yet recruiting Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: VRC01LS
35 Not yet recruiting Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh
Condition: Dengue
Interventions: Biological: TV005 vaccine;   Biological: Placebo
36 Not yet recruiting Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: Bivalent Subtype C gp120/MF59 vaccine;   Biological: Bivalent Subtype C gp120/AS01B vaccine;   Biological: Placebo
37 Recruiting A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow Fever
Interventions: Biological: MVA Smallpox Vaccine;   Biological: YF Vax 17D Strain;   Drug: ISA-720;   Biological: MVA-BN Yellow Fever Vaccine;   Other: Placebo
38 Recruiting Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX®-GP HIV-1 DNA vaccine;   Biological: Interleukin-12 (IL-12) DNA adjuvant;   Biological: Placebo
39 Not yet recruiting Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Condition: HIV Infections
Interventions: Biological: MVA/HIV62B vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo
40 Recruiting Analysis of Lyme Disease Lesions
Conditions: Erythema Migrans Lesions;   Erythema Migrans
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Indicates status has not been verified in more than two years